Business Description
Biocure Technology Inc
NAICS : 325412
SIC : 3741
ISIN : CA09075T1075
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.63 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17 | |||||
3-Year EPS without NRI Growth Rate | 18.1 | |||||
3-Year FCF Growth Rate | 46.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.12 | |||||
9-Day RSI | 36.46 | |||||
14-Day RSI | 41.25 | |||||
6-1 Month Momentum % | 66.67 | |||||
12-1 Month Momentum % | 66.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.09 | |||||
Quick Ratio | 0.09 | |||||
Cash Ratio | 0.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 2 | |||||
Shareholder Yield % | 62.61 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -207.69 | |||||
ROA % | -159.68 | |||||
ROIC % | -43.88 | |||||
ROCE % | -202.92 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.59 | |||||
Price-to-Tangible-Book | 0.5 | |||||
Price-to-Free-Cash-Flow | 10 | |||||
Price-to-Operating-Cash-Flow | 10 | |||||
EV-to-EBIT | -0.23 | |||||
EV-to-EBITDA | -0.23 | |||||
EV-to-FCF | 14.07 | |||||
Earnings Yield (Greenblatt) % | -434.78 | |||||
FCF Yield % | 7.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biocure Technology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.041 | ||
Beta | 4.45 | ||
Volatility % | 33.33 | ||
14-Day RSI | 41.25 | ||
14-Day ATR (C$) | 0.000896 | ||
20-Day SMA (C$) | 0.01125 | ||
12-1 Month Momentum % | 66.67 | ||
52-Week Range (C$) | 0.005 - 0.035 | ||
Shares Outstanding (Mil) | 94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biocure Technology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biocure Technology Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Biocure Technology Inc Frequently Asked Questions
What is Biocure Technology Inc(XCNQ:CURE.X)'s stock price today?
When is next earnings date of Biocure Technology Inc(XCNQ:CURE.X)?
Does Biocure Technology Inc(XCNQ:CURE.X) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |